Anti-Allergy Medicine EpiPen Recall Expands To U.S.

PITTSBURGH (KDKA/AP) -- A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.

The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing. The recall now covers 13 lots distributed from December 2015 through July 2016.

Mylan didn't immediately respond to a question about how many devices are affected by the recall.

The problems could be potentially life-threatening, although Mylan described the incidence of the defects as "extremely rare."

The EpiPen is used to treat allergic reactions to certain food and bug bites.

For much more information on the EpiPen recall, visit: http://www.mylan.com/en/epipenrecall

The products can be replaced at no charge by calling 877-650-3494 or emailing customer@servicemylan.com.

Join The Conversation On The KDKA Facebook Page
Stay Up To Date, Follow KDKA On Twitter

(© Copyright 2017 CBS Broadcasting Inc. All Rights Reserved. The Associated Press contributed to this report.)

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.